Published in J Hypertens on May 01, 2010
Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens (2013) 1.21
Characteristics of sodium sensitivity in Korean populations. J Korean Med Sci (2011) 0.87
Low-Salt Diet and Circadian Dysfunction Synergize to Induce Angiotensin II-Dependent Hypertension in Mice. Hypertension (2016) 0.84
Dietary sodium and nocturnal blood pressure dipping in normotensive men and women. J Hum Hypertens (2016) 0.76
Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia. Hypertension (2013) 2.70
Glycyrrhetinic acid food supplementation lowers serum potassium concentration in chronic hemodialysis patients. Kidney Int (2009) 2.39
Outcome of home haemodialysis patients: a case-cohort study. Nephrol Dial Transplant (2005) 2.21
Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int (2008) 2.00
Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest (2004) 1.87
Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82
Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology (2006) 1.52
Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients. Am J Hypertens (2008) 1.51
Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant (2005) 1.50
High aldosterone-to-renin variants of CYP11B2 and pregnancy outcome. Nephrol Dial Transplant (2009) 1.49
The relative myocardial blood volume differentiates between hypertensive heart disease and athlete's heart in humans. Eur Heart J (2006) 1.45
The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant (2005) 1.44
Reduced 11beta-hydroxysteroid dehydrogenase activity in experimental nephrotic syndrome. Nephrol Dial Transplant (2002) 1.44
Treatment of acute renal failure in the intensive care unit: lower costs by intermittent dialysis than continuous venovenous hemodiafiltration. Artif Organs (2009) 1.43
Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension. J Hypertens (2012) 1.43
Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant (2009) 1.34
Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol (2012) 1.20
Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J (2005) 1.18
First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol (2008) 1.12
Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging. Eur Radiol (2009) 1.07
Effect of tenofovir on renal glomerular and tubular function. AIDS (2007) 1.05
A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab (2003) 1.03
Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms. Circulation (2009) 1.01
Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis (2009) 1.01
Reference values and factors associated with renal resistive index in a family-based population study. Hypertension (2013) 1.00
Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells. Am J Physiol Endocrinol Metab (2008) 1.00
Non-invasive monitoring of renal oxygenation using BOLD-MRI: a reproducibility study. NMR Biomed (2006) 0.97
Prematurity is related to high placental cortisol in preeclampsia. Pediatr Res (2009) 0.95
Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. J Am Soc Nephrol (2007) 0.93
Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol (2011) 0.93
Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle. Am J Pathol (2010) 0.93
Regulation of placental growth by aldosterone and cortisol. Endocrinology (2010) 0.92
Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation (2002) 0.92
Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. J Biol Chem (2002) 0.91
Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet (2008) 0.91
The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist. Mol Cell Endocrinol (2004) 0.91
Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: functional characterization and relevance for salt sensitivity. FASEB J (2007) 0.91
Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics (2011) 0.90
Salt sensitivity of children with low birth weight. Hypertension (2008) 0.90
PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers. Nephrol Dial Transplant (2008) 0.89
Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol (2013) 0.89
Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1. FASEB J (2005) 0.88
Role of the alpha-adducin genotype on renal disease progression. Kidney Int (2002) 0.88
Glutamate-115 renders specificity of human 11beta-hydroxysteroid dehydrogenase type 2 for the cofactor NAD+. Mol Cell Endocrinol (2003) 0.87
In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter: evidence for cell-specific regulation by Sp1 and Sp3. J Biol Chem (2002) 0.87
DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins. J Am Soc Nephrol (2007) 0.87
Intrarenal arterial aneurysms with haematuria in a patient with tuberous sclerosis complex. Nephrol Dial Transplant (2005) 0.87
Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species. J Mol Endocrinol (2005) 0.87
Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. J Am Soc Nephrol (2002) 0.86
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis. J Am Soc Nephrol (2003) 0.86
Arterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD. Am J Kidney Dis (2006) 0.86
Use of Pavo cristatus feather extract for the better management of snakebites: neutralization of inflammatory reactions. J Ethnopharmacol (2005) 0.85
Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant (2007) 0.85
CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. J Clin Endocrinol Metab (2004) 0.85
Nephrotoxicity of rapamycin: an emerging problem in clinical medicine. Nephrol Dial Transplant (2005) 0.84
Urinary proteomics before and after extracorporeal circulation in patients with and without acute kidney injury. J Thorac Cardiovasc Surg (2010) 0.84
Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis. Kidney Int (2002) 0.84
Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids. PLoS One (2007) 0.84
Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis. Thromb Haemost (2007) 0.84
Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade. J Hypertens (2002) 0.83
Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients. J Gastrointest Surg (2005) 0.83
Hypoxia causes down-regulation of 11 beta-hydroxysteroid dehydrogenase type 2 by induction of Egr-1. FASEB J (2003) 0.83
Dynamics of hemodialysis catheter colonization by coagulase-negative staphylococci. Infect Control Hosp Epidemiol (2005) 0.83
'Pergularain e I'--a plant cysteine protease with thrombin-like activity from Pergularia extensa latex. Thromb Res (2009) 0.83
A naturally occurring human Nedd4-2 variant displays impaired ENaC regulation in Xenopus laevis oocytes. Am J Physiol Renal Physiol (2004) 0.83
Living renal allograft transplantation: diffusion-weighted MR imaging in longitudinal follow-up of the donated and the remaining kidney. Radiology (2013) 0.83
Gene delivery by a steroid-peptide nucleic acid conjugate. FASEB J (2002) 0.82
Metabolomics reveals the metabolic map of procainamide in humans and mice. Biochem Pharmacol (2012) 0.82
Smaller left kidney in low birth weight children. Kidney Int (2012) 0.82
Normotensive blood pressure in pregnancy: the role of salt and aldosterone. Hypertension (2013) 0.81
High salt intake down-regulates colonic mineralocorticoid receptors, epithelial sodium channels and 11β-hydroxysteroid dehydrogenase type 2. PLoS One (2012) 0.81
Salt-sensitivity of blood pressure and decreased 11beta-hydroxysteroid dehydrogenase type 2 activity after renal transplantation. Transplantation (2002) 0.81
Effect of transcutaneous electrical muscle stimulation and passive cycling movements on blood pressure and removal of urea and phosphate during hemodialysis. Am J Kidney Dis (2008) 0.81
Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors. Kidney Int (2003) 0.81
Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era. Transpl Int (2006) 0.81
Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients. Clin Pharmacokinet (2002) 0.81
Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivo. J Endocrinol (2013) 0.81
Non-medical factors influencing peritoneal dialysis utilization: the Swiss experience. Nephrol Dial Transplant (2004) 0.80
Cholesterol acceptor capacity is preserved by different mechanisms in preterm and term fetuses. Biochim Biophys Acta (2014) 0.80
Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor. Clin Transplant (2009) 0.80
Pulse contour analysis: a valid assessment of central arterial stiffness in children? Pediatr Nephrol (2007) 0.79
Ambulatory arterial stiffness index is increased in hypertensive childhood disease. Pediatr Res (2008) 0.79